
SteinCares and Shilpa Biologicals Enter Strategic Licensing Agreement to Commercialize Biosimilar in Latin America
SteinCares and Shilpa Biologicals Pvt Ltd have announced a strategic licensing agreement to commercialize a biosimilar therapy across








